Table 5.
Individual Features Performance | ||||||
Rank | Feature | AUC | bACC | Sensitivity | Specificity | |
1 | MAs | 0.8 ± 0.06 | 0.75 ± 0.07 | 0.7 ± 0.14 | 0.79 ± 0.1 | |
2 | MAT_6_months | 0.8 ± 0.06 | 0.7 ± 0.07 | 0.68 ± 0.11 | 0.72 ± 0.1 | |
3 | MAT_12_months | 0.79 ± 0.07 | 0.75 ± 0.06 | 0.66 ± 0.12 | 0.85 ± 0.09 | |
4 | //_FAZCircularity | 0.79 ± 0.07 | 0.71 ± 0.07 | 0.75 ± 0.11 | 0.67 ± 0.14 | |
5 | //_PD_InR_DCP | 0.72 ± 0.07 | 0.67 ± 0.07 | 0.67 ± 0.12 | 0.67 ± 0.13 | |
6 | //_÷[SCP_DCP]_PD_InR | 0.71 ± 0.08 | 0.66 ± 0.08 | 0.64 ± 0.12 | 0.67 ± 0.12 | |
7 | //_FAZPerimeter | 0.69 ± 0.12 | 0.62 ± 0.1 | 0.69 ± 0.16 | 0.55 ± 0.19 | |
8 | //_ VD_InR_DCP | 0.68 ± 0.08 | 0.64 ± 0.06 | 0.66 ± 0.11 | 0.61 ± 0.12 | |
9 | ÷[VD_PD]_InR_DCP | 0.65 ± 0.1 | 0.6 ± 0.1 | 0.56 ± 0.15 | 0.64 ± 0.15 | |
10 | //_÷[SCP_DCP]_VD_InR | 0.64 ± 0.11 | 0.61 ± 0.09 | 0.62 ± 0.14 | 0.61 ± 0.15 | |
FFS Performance - Static features | ||||||
#features | AUC | bACC | Sensitivity | Specificity | Features | |
1 | 0.8 ± 0.06 | 0.75 ± 0.07 | 0.7 ± 0.14 | 0.79 ± 0.1 | MAs | |
2 | 0.84 ± 0.07 | 0.79 ± 0.07 | 0.76 ± 0.14 | 0.82 ± 0.1 | + PD_InR_SCP_6 × 6 | |
3 | 0.84 ± 0.07 | 0.81 ± 0.08 | 0.79 ± 0.13 | 0.83 ± 0.12 | + triglycerides | |
4 | 0.84 ± 0.07 | 0.81 ± 0.08 | 0.8 ± 0.14 | 0.83 ± 0.11 | + ÷[VD_PD]_OutR_SCP_6 × 6 | |
5 | 0.84 ± 0.07 | 0.82 ± 0.08 | 0.81 ± 0.13 | 0.83 ± 0.12 | + RT_Inr_GCL | |
FFS Performance - Static + Dynamic features | ||||||
#features | AUC | bACC | Sensitivity | Specificity | Features | |
1 | 0.8 ± 0.06 | 0.75 ± 0.07 | 0.7 ± 0.14 | 0.79 ± 0.1 | MAs | |
2 | 0.87 ± 0.05 | 0.78 ± 0.06 | 0.76 ± 0.12 | 0.79 ± 0.1 | + //_FAZCircularity | |
3 | 0.89 ± 0.06 | 0.83 ± 0.06 | 0.83 ± 0.09 | 0.82 ± 0.11 | + //_ PD_InR_DCP_6 × 6 | |
4 | 0.91 ± 0.05 | 0.81 ± 0.09 | 0.81 ± 0.14 | 0.8 ± 0.12 | + ÷[SCP_DCP]_PD_OurR_6 × 6 | |
5 | 0.91 ± 0.05 | 0.84 ± 0.08 | 0.84 ± 0.12 | 0.83 ± 0.11 | + //_÷[VD_PD]_InR_SCP_6 × 6 |
Notation: //—slope measured between the baseline and the 12-month follow-up; MA—microaneurysm; MAT—microaneurysm turnover; VD—skeletonized vessel density; PD—perfusion density; SCP—superficial capillary plexus; DCP—deep capillary plexus; InR—inner ring; OutR—outer ring; 6 × 6—6 × 6 mm angiography acquisition protocol; ÷[SCP_DCP]—ratio between the values measured at the SCP and DCP; ÷[VD_PD]—ratio between the measured values of VD and PD; FAZCircularity—circularity of the foveal avascular zone; FAZPerimeter—perimeter of the foveal avascular zone.